Company page

Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc. (ticker: GLUE) is a public company based in the United States, with a market capitalization of approximately $1.55 billion. The company focuses on developing innovative therapies to address unmet medical needs. Monte Rosa is committed to advancing its research and development efforts in the biopharmaceutical sector.